A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Start and Thesaurus | Brand Names | DMF Index | Search | Services | Site Map

Kaletra (lopinavir) oral solution, lopinavir/ ritonavir.Patient Package Insert. Abbott 21-251 9/15/00 9/18/00 9/18/00 3/26/02 Kaletra Indication:Kaletra is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infections in adults and pediatric patients age six months and older. Kaletra (lopinavir/ritonavir) Abbott 21-226/S6 & 21-251/S5 11/27/02 12/4/02 Kaletra (lopinavir/ritonavir) Abbott 21-226/S3 & 21-251/S4 1/18/02 2/5/02 2/5/02 3/26/02 Kaletra (lopinavir/ritonavir) Capsules & Solution, 133.3/33. Capsules and 80/ Solution., Abbott 21-226/S2 & 21-251/S2 3/13/01 4/25/01 3/26/02 3/26/02 Kaletra (lopinavir) 133. lopinavir/33. ritonavir. Patient Package Insert Abbott 21-226 9/15/00 9/18/00 9/18/00 3/26/02 Kaletra Indication: Kaletra is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infections in adults and pediatric patients age six months and older. Kaletra (lopinavir/ritonavir) Abbott Laboratories | KALETRA (lopinavir/ritonavir) capsules, Abbott Labs, Labeling Revision | KALETRA (lopinavir/ritonavir) oral solution, Abbott Labs, Labeling Revision | KALETRA (lopinavir/ritonavir) capsules, Abbott Labs, New Dosage Regimen

For the most up-to-date approval information, please locate this API using the drug index. For industry specific content, please visit USActives.com.